Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia Michael W. N. Deininger Review 07 November 2003 Pages: 59 - 72
Induction of differentiation and peroxisome proliferator-activated receptor γ expression in colon cancer cell lines by troglitazone Masashi KatoTomomi KusumiHajime Kudo Original Paper 21 November 2003 Pages: 73 - 79
Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma Anil PottiNauman MoazzamSteve Kargas Original Paper 21 November 2003 Pages: 80 - 86
Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma Vajarabhongsa BhudhisawasdiKanha MuisukSopit Wongkham Original Paper 28 November 2003 Pages: 87 - 92
Report of a user-satisfaction analysis of a service provider for an oncology clinic Michael HartmannHolger KnothDaniel Kühne Original Paper 28 November 2003 Pages: 93 - 98
Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer Hiromasa TsukinoYoshiki KurodaTakahiko Katoh Original Paper 27 November 2003 Pages: 99 - 106
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphoma Hisashi TsurumiToshiki YamadaHisataka Moriwaki Original Paper 27 November 2003 Pages: 107 - 113
The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma Bożena KonopkaAneta Janiec-JankowskaMarian Goluda Original Paper 09 December 2003 Pages: 114 - 121
Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder M. BirlikS. AkarN. Akkoc Rapid Communication 27 January 2004 Pages: 122 - 125